Sara Reardon
Nature Magazine
Bozeman, MT, United States
Contact Sara
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Sara:
Octopuses used in research could receive same protections as monkeys
For the first time in the United States, research with cephalopods might require approval by an ethics committee. → Read More
Psychedelic drug MDMA moves closer to US approval following success in PTSD trial
Long-awaited trial data show drug is effective at treating post-traumatic stress disorder in a diversity of people. → Read More
Mind-reading machines are here: is it time to worry?
Neuroethicists are split on whether a study that uses brain scans and AI to decode imagined speech poses a threat to mental privacy. → Read More
US could soon approve MDMA therapy — opening an era of psychedelic medicine
Perceptions have shifted dramatically in the past few years on the therapeutic value of illicit drugs such as ecstasy. But questions still linger about what FDA approval might look like. → Read More
What Does the Future of Monkeypox Look Like?
With cases declining in the U.S. and Europe, here are some scenarios of how the outbreak might play out → Read More
Long COVID Risk Falls Only Slightly after Vaccination
Results from a large study suggest that vaccines offer less protection against lingering symptoms than expected → Read More
Jury finds University of Kansas chemical engineer guilty of hiding ties to China
After a two-week trial, Feng “Franklin” Tao was convicted on 4 of 8 charges — but a judge is reviewing the case. → Read More
A Simple Solution Would Make COVID Antivirals More Accessible, Pharmacists Say
The Biden administration’s Test to Treat program aims to make the treatments available at pharmacies, yet it requires a medical provider to prescribe the drugs → Read More
When Should You Get a COVID Test?
It depends, but vaccinated people should generally wait five days after exposure before taking an antigen test. Here’s why → Read More
First pig-to-human heart transplant: what can scientists learn?
Researchers hope that a person who has so far lived for a week with a genetically modified pig heart will provide a trove of data on the possibilities of xenotransplantation. → Read More
Cuba’s bet on home-grown COVID vaccines is paying off
Preprint data show that a three-dose combo of Soberana jabs has 92.4% efficacy in clinical trials. → Read More
Genetic patterns offer clues to evolution of homosexuality
Massive study finds that genetic markers associated with same-sex encounters might aid reproduction. But some scientists question the conclusions. → Read More
The True Haiti Earthquake Death Toll Is Much Worse than Early Official Counts
A tool built by the U.S. Geological Survey suggests that the number of fatalities may range from 10,000 to 100,000 or more → Read More
Flawed ivermectin preprint highlights challenges of COVID drug studies
The study, now withdrawn, deals a blow to the anti-parasite drug’s chances as a COVID treatment, researchers say. → Read More
A complete human genome sequence is close: how scientists filled in the gaps
Researchers added 200 million DNA base pairs and 115 protein-coding genes — but they’ve yet to entirely sequence the Y chromosome. → Read More
The U.K. Coronavirus Mutation Is Worrying but Not Terrifying
There is evidence the new variant could be more transmissible, yet vaccines work very well against it → Read More
Who Will Get COVID Vaccines First and Who Will Have to Wait?
In the U.S., health workers come first, but for other groups scientists and policy makers are weighing a mix of disease risks, logistics and ethics → Read More
Not All Americans Can Get A COVID-19 Test When They Want One
Animation by Donald Pearsall In many cities in America, your access to COVID-19 testing depends on the color of your skin. FiveThirtyEight and ABC News spent months reporting on the state of testing access in America. Watch the video and explore which cities have the biggest racial disparities in testing. → Read More
How A 60-Year-Old Drug Became Our Best Hope For Saving People With COVID-19
Animation by Donald Pearsall Dexamethasone, a steroid that appears promising for COVID-19 patients, has a long and storied history in medicine. We talk with experts about its many uses, and explore how it might save lives in this pandemic. → Read More
How A Scientific Paper About A Promising COVID-19 Treatment Was Debunked
When a paper in a major medical journal reported that hydroxychloroquine harmed COVID-19 patients, it made big news. But a group of Twitter sleuths uncovered evidence that not only was the paper inaccurate, but the data may even have been fabricated. How could this paper have been released in the first place? And what does it tell us about how science gets shared? → Read More